Liver Enzymes Reductions From Baseline Over Time in Resmetirom-Treated Patients in a Phase 3 Study, MAESTRO-NASH
Gastroenterol Hepatol (N Y)
.
2024 Dec;20(12 Suppl 11):14-15.
PMID:
39896963
PMCID:
PMC11784559
No abstract available